The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Francisca Guardiola-Serrano; Roberto Beteta-Gobel; Raquel Rodriguez-Lorca; Maitane Ibarguren; David J. Lopez; Silvia Teres; Rafael Alvarez; Maria Alonso-Sande; Xavier Busquets; Pablo Vicente Escriba

doi:10.1124/jpet.114.222281

Research ArticleDrug Discovery and Translational Medicine

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Francisca Guardiola-Serrano, Roberto Beteta-Gobel, Raquel Rodriguez-Lorca, Maitane Ibarguren, David J. Lopez, Silvia Teres, Rafael Alvarez, Maria Alonso-Sande, Xavier Busquets and Pablo Vicente Escriba

Journal of Pharmacology and Experimental Therapeutics June 11, 2015, jpet.114.222281; DOI: https://doi.org/10.1124/jpet.114.222281

Francisca Guardiola-Serrano

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roberto Beteta-Gobel

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raquel Rodriguez-Lorca

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maitane Ibarguren

2 University of the Balearic Islands and Lipopharma Therapeutics S.L

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David J. Lopez

2 University of the Balearic Islands and Lipopharma Therapeutics S.L

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Silvia Teres

2 University of the Balearic Islands and Lipopharma Therapeutics S.L

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rafael Alvarez

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Alonso-Sande

2 University of the Balearic Islands and Lipopharma Therapeutics S.L

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xavier Busquets

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pablo Vicente Escriba

1 University of the Balearic Islands;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Article Figures & Data

Additional Files

Data Supplement

Files in this Data Supplement:

Supplemental Data - Supplemental methods, 3 tables, 3 figures.

In this issue

Journal of Pharmacology and Experimental Therapeutics

Vol. 387, Issue 1

1 Oct 2023

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Editorial Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Message Subject (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics

Message Body (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Research ArticleDrug Discovery and Translational Medicine

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Journal of Pharmacology and Experimental Therapeutics June 11, 2015, jpet.114.222281; DOI: https://doi.org/10.1124/jpet.114.222281

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Research ArticleDrug Discovery and Translational Medicine

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Journal of Pharmacology and Experimental Therapeutics June 11, 2015, jpet.114.222281; DOI: https://doi.org/10.1124/jpet.114.222281

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
Info & Metrics
eLetters
PDF + SI
PDF

Main menu

User menu

Search

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Article Figures & Data

Additional Files

Data Supplement

In this issue

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

More Information

ASPET's Other Journals